Surgery for limited liver or lung pancreatic cancer spread
Part of Cancer clinical trials.
This trial tests whether removing or ablating limited liver or lung tumors from pancreatic cancer that has not spread elsewhere, along with a specific chemotherapy (NALIRIFOX), can help patients. It is for people who have not had any previous cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer that has spread to only 1 to 5 spots in the liver or up to 4 spots in the lung, and no other distant spread.
- You have not received any prior cancer treatments for this pancreatic cancer.
- You are able to do your daily activities with little or no help (ECOG 0-1).
- You are age 18 or older.
- You are a candidate for a chemotherapy regimen called NALIRIFOX.
- You do not have active hepatitis B or C, HIV, or Gilbert's syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with pancreatic cancer that has spread to the liver (3 spots or fewer). It tests whether removing both the original tumor and the liver spots after a specific chemotherapy (FOLFIRINOX) can be helpful. You may be eligible if the chemo shrinks the tumors enough and you are healthy enough for surgery.
This trial compares surgery to remove the primary tumor and up to 3 liver spots against standard palliative care for people with pancreatic cancer that has spread only to the liver (up to 3 spots). It is for those whose cancer has not grown after initial chemotherapy and who are healthy enough for surgery.
This trial studies outcomes of surgery (and sometimes heating/cutting techniques) for pancreatic cancer that has spread only to the liver. It’s for people whose liver tumors can potentially be removed with curative intent, aiming to improve long-term results after local treatment.
This trial tests a combination of chemotherapy drugs (liposomal irinotecan with fluorouracil, leucovorin, and oxaliplatin) given before and after surgery for pancreatic cancer that can be fully removed. It aims to see if this approach improves outcomes for patients with stage I or II disease.
This trial tests a treatment called PIPAC, where chemotherapy is sprayed as a mist into the abdomen during a minimally invasive surgery. It is for people whose pancreatic cancer has spread to the lining of the belly, and aims to see if this approach is safe and helpful.
This trial tests a combination of chemotherapy drugs (NALIRIFOX given through a vein plus paclitaxel given directly into the abdomen) for people with pancreatic cancer that has spread to the lining of the belly but not to other organs. The goal is to see if this approach is safe and effective.
Hear when a new Adenocarcinoma of the Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.